SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Biotech Bay
NKarta Therapeutics’ NK Cells Elicit Better Response than CAR-T Cells Alone
NKarta Therapeutics is using engineered chimeric antigen receptor natural killer cells (CAR-NK cells) for allogeneic therapy, showing substantial benefits both in vitro and in vivo, according to James Trager, CSO, speaking Wednesday at the virtual CAR-TCR Summit – Europe.
February 18, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
New Collaboration Could Help Answer Questions about COVID-19 Reinfections
COVID-19 reinfections are occurring but, so far, scientists don’t have all the details.
February 17, 2021
 · 
4 min read
 · 
Gail Dutton
Photo Courtesy of Cohbar, Inc.
Biotech Bay
Mitochondrial-based Therapies Offer New Ways to Tackle Acute and Chronic Conditions
CohBar, Inc. is pioneering mitochondrial-based therapies with a candidate in a Phase Ia/Ib clinical trial as a potential treatment for nonalcoholic steatohepatitis (NASH) and obesity, where top-line results are expected later this year.
February 12, 2021
 · 
6 min read
 · 
Gail Dutton
Bio NC
Precision’s Stealth Cell Allogeneic CAR T Candidate Engineered for Persistence
Precision BioSciences recently received a notice of allowance for a new patent for PBCAR19B, its stealth cell, CD19 allogeneic CAR T candidate for non-Hodgkin lymphoma.
February 11, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Immunai Gets Series A Funding for Genomics Database Advancements
Immunai today announced it has received $60 million in Series A funding, bringing its total funding since inception in December 2018 to $80 million.
February 11, 2021
 · 
4 min read
 · 
Gail Dutton
Courtesy of Alexanderstock23/Shutterstock
Drug Development
Switzerland Delays AstraZeneca Vaccine Approval, Wanting More Data
The Swiss health authority Swissmedic rejected AstraZeneca’s rolling authorization application for its COVID-19 vaccine a few days ago, saying more data is needed “to obtain more information about safety, efficacy, and quality.”
February 5, 2021
 · 
3 min read
 · 
Gail Dutton
BioMidwest
St. Louis Researchers ID 1-Step Method to Clear HIV Cells Before They Activate
Treatments for HIV are poised for another breakthrough. Researchers at Washington University in St. Louis (WUSTL) have discovered a way to eradicate dormant HIV virus within the cells, before it becomes active.
February 4, 2021
 · 
4 min read
 · 
Gail Dutton
Courtesy Shutterstock
Genetown
Novavax Stock Hits All-time High, Exceeding Even Gamestop’s Gains
Although Gamestop dominated the financial news this week, surging more than 1,600% in January, Novavax actually saw greater growth in 2020, with year-to-year gains of 2,731% that exceeded those of all the coronavirus stocks.
February 2, 2021
 · 
4 min read
 · 
Gail Dutton
Novel Therapeutic May Offer Complete Response for Immuno-Inflammatory Diseases
There are severely limited therapeutic options for immuno-inflammatory diseases such as acute graft vs. host disease (aGVHD), lupus and asthma.
January 29, 2021
 · 
5 min read
 · 
Gail Dutton
Jonathan Weiss/Shutterstock
European Commission Raids AstraZeneca’s Belgian Vaccine Plant
Regulators removed samples and records from the plant, which are being examined by experts from Belgium, the Netherlands, Italy, and Spain.
January 28, 2021
 · 
4 min read
 · 
Gail Dutton
Cheriss May/NurPhoto via Getty Images
Policy
DoJ Set to Recover More Than $3 Billion from Healthcare Fraud in 2021
The U.S. Department of Justice is set to recover more than $3 billion this year from pharmaceutical and medical device manufacturers as well as healthcare providers, labs and pharmacies found guilty of healthcare fraud under the False Claims Act.
January 28, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
UK Offers Genomics Expertise to Help Nations ID New SARS-CoV-2 Variants
On Tuesday, the U.K. offered its genomics expertise to identify emerging variants of the SARS-CoV-2 virus to countries that lack the resources to make such identifications.
January 27, 2021
 · 
4 min read
 · 
Gail Dutton
Business
47% of Americans Still Hesitant to Get COVID-19 Vaccine, New Poll Says
Americans are still hesitant to be vaccinated against COVID-19, according to just-released research from Invisibly.
January 22, 2021
 · 
4 min read
 · 
Gail Dutton
Photo courtesy of Kura Oncology.
Business
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
Precision medicine developer Kura Oncology is positioned to make a meaningful difference in the treatment of cancer in the next few years with its two, wholly-owned, small molecule compounds.
January 20, 2021
 · 
4 min read
 · 
Gail Dutton
n-Lorem Foundation Preps First Doses to Treat Ultra-Rare Disease Patients for Free
n-Lorem Foundation has taken on a challenge that many nations consider too great: treating patients with ultra-rare diseases (which affect 30 or fewer people) for free, for life.
January 18, 2021
 · 
4 min read
 · 
Gail Dutton
Load More